Harry Le

Harry Le has worked in the pharmaceutical industry since 2000. Harry began their career at Gilead Sciences as a Formulation Scientist, where they specialized in formulation development for liposome injectable drug products. In 2004, they moved to Beckman Coulter as a Clinical Reagent Development Scientist, where they evaluated and implemented new diagnostic reagents, calibration standards, and controls on Beckman Coulter SYNCHRON systems. In 2005, they joined Teva Pharmaceuticals as a Formulation Scientist, where they developed formulations for injectable drug products. In 2015, they moved to Nitto Avecia Pharma Services as a Senior Formulation Scientist, where they were the lead formulation scientist for early clinical to FDA submission parenteral products. Harry is currently employed at Reflow Medical as a Principal Formulation Scientist, where they are responsible for R&D and CMC for drug coated stents.

Harry Le earned a Bachelor of Science in Biology from California State Polytechnic University-Pomona and California Polytechnic State University-Pomona between 1997 and 1999.